|
Coagulation inhibitors
Citations 1-10 of 43 total displayed.
|
Most recent content
(30 Jun 2009):
|
- Interventional Cardiology
Intensifying Platelet Inhibition With Tirofiban in Poor Responders to Aspirin, Clopidogrel, or Both Agents Undergoing Elective Coronary Intervention: Results From the Double-Blind, Prospective, Randomized Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel Study
- Marco Valgimigli, Gianluca Campo, Nicoletta de Cesare, Emanuele Meliga, Pascal Vranckx, Alessandro Furgieri, Dominick J. Angiolillo, Manel Sabatè, Martial Hamon, Alessandra Repetto, Salvatore Colangelo, Salvatore Brugaletta, Giovanni Parrinello, Gianfranco Percoco, Roberto Ferrari for the Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R) Investigators
Circulation 2009;119:3215-3222; published online before print as doi:10.1161/CIRCULATIONAHA.108.833236
[Abstract]
[Full text]
|
Past content
(since Apr 2001):
|
- Articles
Intensifying Platelet Inhibition With Tirofiban in Poor Responders to Aspirin, Clopidogrel, or Both Agents Undergoing Elective Coronary Intervention. Results From the Double-Blind, Prospective, Randomized Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel Study
- Marco Valgimigli, Gianluca Campo, Nicoletta de Cesare, Emanuele Meliga, Pascal Vranckx, Alessandro Furgieri, Dominick J. Angiolillo, Manel Sabatè, Martial Hamon, Alessandra Repetto, Salvatore Colangelo, Salvatore Brugaletta, Giovanni Parrinello, Gianfranco Percoco, Roberto Ferrari for the Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R) Investigators
Circulation published June 15, 2009, doi:10.1161/CIRCULATIONAHA.108.833236
[Abstract]
- Editorials
What to Do With Patients Receiving Long-Term Clopidogrel: Reload or Relax?
- David O. Williams and J. Dawn Abbott
Circulation 2008;118:1219-1222, doi:10.1161/CIRCULATIONAHA.108.804229
[Full text]
- Coronary Heart Disease
Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease
- Mark Y. Chan, Mauricio G. Cohen, Christopher K. Dyke, Shelley K. Myles, Laura G. Aberle, Min Lin, James Walder, Steven R. Steinhubl, Ian C. Gilchrist, Neal S. Kleiman, David A. Vorchheimer, Nicholas Chronos, Chiara Melloni, John H. Alexander, Robert A. Harrington, Ross M. Tonkens, Richard C. Becker, and Christopher P. Rusconi
Circulation 2008;117:2865-2874; published online before print as doi:10.1161/CIRCULATIONAHA.107.745687
[Abstract]
[Full text]
- Articles
Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease
- Mark Y. Chan, Mauricio G. Cohen, Christopher K. Dyke, Shelley K. Myles, Laura G. Aberle, Min Lin, James Walder, Steven R. Steinhubl, Ian C. Gilchrist, Neal S. Kleiman, David A. Vorchheimer, Nicholas Chronos, Chiara Melloni, John H. Alexander, Robert A. Harrington, Ross M. Tonkens, Richard C. Becker, and Christopher P. Rusconi
Circulation published May 27, 2008, doi:10.1161/CIRCULATIONAHA.107.745687
[Abstract]
- Coronary Heart Disease
Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention: The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation–Thrombolysis in Myocardial Infarction 44 Trial
- Stephen D. Wiviott, Dietmar Trenk, Andrew L. Frelinger, Michelle O’Donoghue, Franz-Josef Neumann, Alan D. Michelson, Dominick J. Angiolillo, Hanoch Hod, Gilles Montalescot, Debra L. Miller, Joseph A. Jakubowski, Richard Cairns, Sabina A. Murphy, Carolyn H. McCabe, Elliott M. Antman, Eugene Braunwald for the PRINCIPLE-TIMI 44 Investigators
Circulation 2007;116:2923-2932; published online before print as doi:10.1161/CIRCULATIONAHA.107.740324
[Abstract]
[Full text]
- Articles
Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention. The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation–Thrombolysis in Myocardial Infarction 44 Trial
- Stephen D. Wiviott, Dietmar Trenk, Andrew L. Frelinger, Michelle O'Donoghue, Franz-Josef Neumann, Alan D. Michelson, Dominick J. Angiolillo, Hanoch Hod, Gilles Montalescot, Debra L. Miller, Joseph A. Jakubowski, Richard Cairns, Sabina A. Murphy, Carolyn H. McCabe, Elliott M. Antman, Eugene Braunwald for the PRINCIPLE-TIMI 44 Investigators
Circulation published December 3, 2007, doi:10.1161/CIRCULATIONAHA.107.740324
[Abstract]
- Editorials
A Replacement for Warfarin: The Search Continues
- John W. Eikelboom and Jeffrey I. Weitz
Circulation 2007;116:131-133; published online before print as doi:10.1161/CIRCULATIONAHA.107.712349
[Full text]
- Vascular Medicine
Treatment of Proximal Deep-Vein Thrombosis With the Oral Direct Factor Xa Inhibitor Rivaroxaban (BAY 59-7939): The ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) Study
- Giancarlo Agnelli, Alexander Gallus, Samuel Z. Goldhaber, Sylvia Haas, Menno V. Huisman, Russel D. Hull, Ajay K. Kakkar, Frank Misselwitz, Sebastian Schellong for the ODIXa-DVT Study Investigators
Circulation 2007;116:180-187; published online before print as doi:10.1161/CIRCULATIONAHA.106.668020
[Abstract]
[Full text]
- Articles
A Replacement for Warfarin. The Search Continues
- John W. Eikelboom and Jeffrey I. Weitz
Circulation published June 18, 2007, doi:10.1161/CIRCULATIONAHA.107.712349
[Abstract]
|
|
